Saturday, June 13, 2026
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

FDA’s E-Cigarette Authorization: Fruity Vapes Not Better Than Tobacco Ones

June 13, 2026
in Health News
Share on FacebookShare on Twitter


Fruit-flavored e-cigarettes recently authorized by the FDA were not significantly better at helping smokers quit than tobacco-flavored e-cigarettes, according to a new memo that’s likely to stir new questions about the agency’s decision.

The FDA last month gave its first OK to fruit-flavored vapes — essentially endorsing them as a less-harmful alternative to traditional cigarettes. The decision came despite the agency’s longstanding position that such flavors appeal to children and must show extra health benefits to warrant approval for adults.

Health groups and Washington lawmakers quickly condemned the decision and have called for an explanation.

A six-page FDA memo released this week provides more details about the agency’s rationale. In it, FDA regulators appear to sidestep previous statements about the risks of sweet vaping flavors while acknowledging shortcomings in the data submitted by vape manufacturer Glas Inc.

To meet federal standards, companies must show that their products benefit public health. In practice, that means demonstrating that their vapes help adult smokers switch or quit cigarettes, while not attracting underage use by teens.

Smokers who tried Glas vapes were much more likely to completely switch from cigarettes over the course of a 3-month study, according to the memo.

But the data did not show “statistically significant differences” between adults using the company’s mango and blueberry flavors and those using a tobacco-flavored e-cigarette.

That means the new vapes failed to meet the same bar as a handful of other flavored products previously sanctioned by the FDA, including menthol-flavored vapes from Juul and NJOY. Those companies showed that adults who used menthol were significantly more likely to cut down or quit cigarettes compared with those vaping tobacco flavors.

Elsewhere, FDA regulators explained that the Glas flavored vapes “did not have to demonstrate added adult benefit,” because young people were unlikely to use them. Glas requires users to unlock each e-cigarette with an age-verifying cellphone app.

The agency’s authorization also runs counter to recent FDA guidelines advising companies that fruit and dessert flavors would have to meet “a high evidentiary burden” for adult use, given their risks to children. Tobacco-flavored products are not popular with teens and generally face lower regulatory hurdles at the FDA.

The FDA document is also unusual in its brevity.

Previous FDA memos on new vaping products typically run dozens of pages. For example, last year’s document authorizing Juul’s menthol e-cigarettes was more than 90 pages and included detailed scientific data from research involving 50,000 people.

The short memo on Glas does not include key details, such as how many smokers the firm studied.

Previously, the FDA almost always posted such memos immediately after announcing an authorization. The document on Glas appeared on the agency’s website more than a month after regulators OK’d the products.

The agency has faced questions from members of Congress about the decision. Last month, 10 Democratic senators sent a letter to the agency requesting more information about the authorization, calling it a “shortsighted and reckless decision.”

The application from Glas, which also included menthol and tobacco-flavored vapes, followed a winding path to authorization. The small, Los Angeles-based company submitted a marketing request to the FDA in 2021, and regulators initially rejected it.

In February, FDA scientists changed course and signed off on several flavors. But that decision was blocked by a senior official reporting to then-FDA Commissioner Marty Makary, MD, MPH, according to internal memos later released by the agency.

The mango- and blueberry-flavored products were finally OK’d during Makary’s last full week leading the agency. He resigned the post after months of criticisms from industry stakeholders, including tobacco companies that have lobbied President Donald Trump’s Republican White House for looser regulations on vaping flavors.

A spokesperson for the company could not immediately provide comment when reached Thursday morning.



Source link : https://www.medpagetoday.com/washington-watch/fdageneral/121724

Author :

Publish date : 2026-06-13 14:00:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

Endocrine Society Issues First Guideline on Central Precocious Puberty

Next Post

In Our Dog-Eat-Dog Medical Culture, Physicians Lose

Related Posts

Health News

Visceral Fat and Cardiometabolic Risk Factors; Autoantibodies and IBD

June 13, 2026
Health News

In Our Dog-Eat-Dog Medical Culture, Physicians Lose

June 13, 2026
Health News

Endocrine Society Issues First Guideline on Central Precocious Puberty

June 13, 2026
Health News

Talquetamab Regimens Boost Survival in Multiple Myeloma

June 13, 2026
Health News

NHS Faces ‘Triple Whammy’ During Resident Doctor Walkout

June 13, 2026
Health News

Over-the-Counter CGM Okayed for Kids

June 13, 2026
Load More

Visceral Fat and Cardiometabolic Risk Factors; Autoantibodies and IBD

June 13, 2026

In Our Dog-Eat-Dog Medical Culture, Physicians Lose

June 13, 2026

FDA’s E-Cigarette Authorization: Fruity Vapes Not Better Than Tobacco Ones

June 13, 2026

Endocrine Society Issues First Guideline on Central Precocious Puberty

June 13, 2026

Talquetamab Regimens Boost Survival in Multiple Myeloma

June 13, 2026

NHS Faces ‘Triple Whammy’ During Resident Doctor Walkout

June 13, 2026

Over-the-Counter CGM Okayed for Kids

June 13, 2026

Why People Using GLP-1s Are Less Likely to Exercise

June 13, 2026
Load More

Categories

Archives

June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« May    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version